Tia L. Bush - May 24, 2023 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
Chief Quality Officer
Signature
/s/ Gregory Weinhoff, attorney-in-fact
Stock symbol
CNTA
Transactions as of
May 24, 2023
Transactions value $
-$35,865
Form type
4
Date filed
5/26/2023, 05:01 PM
Previous filing
Apr 4, 2023
Next filing
Jul 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNTA Ordinary Shares Sale -$22.4K -5K -62.5% $4.49 3K May 24, 2023 By spouse F1
transaction CNTA Ordinary Shares Sale -$13.4K -3K -100% $4.48 0 May 24, 2023 By spouse F1
holding CNTA Ordinary Shares 157K May 24, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.